Having been formally notified of the proposed transaction on April 4, the European Commission confirmed on May 12 that it would undertake an in-depth investigation into whether the planned US$1·8bn acquisition of Faiveley Transport by Wabtec of the USA is in line with the EU Merger Regulation.
The investigation had been expected by Wabtec, and does not prejudge the outcome. The Commission has 90 working days (until September 20) to take a decision.
The Commission said it was concerned that the takeover may reduce competition in the railway systems and subsystems market in the European Economic Area. It has particular concerns about braking systems and pantographs, where it said the technical and regulatory requirements pose high barriers to market entry.
The Commission said its initial investigation had shown that the proposed merger would ‘remove a significant competitor from an already concentrated market’. It also had concerns that the remaining manufacturers ‘would be unable to sufficiently compete with and constrain the merged entity to ensure continued innovation and avoid price increases for customers’.
‘Europe is also home to many manufacturers of locomotives and other rolling stock’, said Commissioner for Competition Margrethe Vestager. ‘The Commission must make sure that Wabtec’s takeover of Faiveley does not restrict effective competition and lead to less innovation in this technology-driven market, or to price increases for manufacturers, train operators and ultimately passengers.’
Full Content: Railway Gazette
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas